HEADER BLOOD CLOTTING 07-DEC-99 1C5G TITLE PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN ACTIVATOR INHIBITOR-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PAI-1; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: LATENT FORM SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PPAIST-7HS KEYWDS SERPIN, SERINE PROTEASE INHIBITOR, PLASMA, PLASMINOGEN KEYWDS 2 ACTIVATION, GLYCOPROTEIN, POLYMORPHISM, SIGNAL, 3D- KEYWDS 3 STRUCTURE, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR E.J.GOLDSMITH REVDAT 3 24-FEB-09 1C5G 1 VERSN REVDAT 2 01-APR-03 1C5G 1 JRNL REVDAT 1 17-DEC-99 1C5G 0 JRNL AUTH H.M.TUCKER,J.MOTTONEN,E.J.GOLDSMITH,R.D.GERARD JRNL TITL ENGINEERING OF PLASMINOGEN ACTIVATOR INHIBITOR-1 JRNL TITL 2 TO REDUCE THE RATE OF LATENCY TRANSITION. JRNL REF NAT.STRUCT.BIOL. V. 2 442 1995 JRNL REFN ISSN 1072-8368 JRNL PMID 7664104 JRNL DOI 10.1038/NSB0695-442 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.MOTTENEN,A.STRAND,J.SYMERSKY,R.M.SWEET, REMARK 1 AUTH 2 D.E.DANLEY,K.F.GEOGHEGAN,R.D.GERARD,E.J.GOLDSMITH REMARK 1 TITL STRUCTURAL BASIS OF LATENCY IN PLASMINOGEN REMARK 1 TITL 2 ACTIVATOR INHIBITOR-1 REMARK 1 REF NATURE V. 355 270 1992 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/355270A0 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.J.GOLDSMITH,C.SHENG-CHENG,D.E.DANLEY,R.D.GERARD, REMARK 1 AUTH 2 K.F.GEOGHEGAN,J.MOTTENEN,A.STRAND REMARK 1 TITL PRELIMINARY X-RAY ANALYSIS OF CRYSTALS OF REMARK 1 TITL 2 PLASMINOGEN ACTIVATOR INHIBITOR-1 REMARK 1 REF PROTEINS V. 9 225 1991 REMARK 1 REFN ISSN 0887-3585 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.4 REMARK 3 NUMBER OF REFLECTIONS : 12239 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3013 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PAR19X.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPH19X.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: PEPTIDE GEOMETRY TO GIVE REMARK 3 RAMACHANDRAN ET AL BBA 359:298 (1974); PEPTIDE TORSIONS FROM REMARK 3 HAGLER ET AL JACS 98:4600 (1976); NONBONDED TERMS JORGENSEN REMARK 3 JACS 103:3976; W/ RC1-4 = 1.80 EC1-4 = 0.1 REMARK 4 REMARK 4 1C5G COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-99. REMARK 100 THE RCSB ID CODE IS RCSB001360. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JAN-99 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : XUONG-HAMLIN MULTIWIRE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SDMS DETECTOR SYSTEM (NIELSEN) REMARK 200 DATA SCALING SOFTWARE : FAST REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 78.79500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.92000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 78.79500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.92000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 MET A 3 REMARK 465 SER A 4 REMARK 465 PRO A 5 REMARK 465 ALA A 6 REMARK 465 LEU A 7 REMARK 465 THR A 8 REMARK 465 CYS A 9 REMARK 465 LEU A 10 REMARK 465 VAL A 11 REMARK 465 LEU A 12 REMARK 465 GLY A 13 REMARK 465 LEU A 14 REMARK 465 ALA A 15 REMARK 465 LEU A 16 REMARK 465 VAL A 17 REMARK 465 PHE A 18 REMARK 465 GLY A 19 REMARK 465 GLU A 20 REMARK 465 GLY A 21 REMARK 465 SER A 22 REMARK 465 ALA A 23 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 49 42.86 -83.10 REMARK 500 SER A 50 174.63 175.09 REMARK 500 LYS A 51 -81.49 -89.60 REMARK 500 ASP A 52 54.46 -118.25 REMARK 500 LYS A 111 -60.75 70.35 REMARK 500 ASN A 173 50.70 73.27 REMARK 500 PHE A 212 81.21 38.97 REMARK 500 HIS A 213 16.46 -68.79 REMARK 500 ASP A 216 82.53 -68.14 REMARK 500 SER A 218 -157.52 -160.70 REMARK 500 PRO A 239 -23.45 -38.78 REMARK 500 ARG A 291 89.06 -69.53 REMARK 500 MET A 318 78.10 -102.59 REMARK 500 SER A 367 112.76 59.68 REMARK 500 ALA A 368 -171.52 169.99 REMARK 500 PRO A 372 128.92 -25.86 REMARK 500 ASP A 378 159.25 179.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B3K RELATED DB: PDB REMARK 900 PAI-1 ACTIVE FORM DBREF 1C5G A 1 402 UNP P05121 PAI1_HUMAN 1 402 SEQRES 1 A 402 MET GLN MET SER PRO ALA LEU THR CYS LEU VAL LEU GLY SEQRES 2 A 402 LEU ALA LEU VAL PHE GLY GLU GLY SER ALA VAL HIS HIS SEQRES 3 A 402 PRO PRO SER TYR VAL ALA HIS LEU ALA SER ASP PHE GLY SEQRES 4 A 402 VAL ARG VAL PHE GLN GLN VAL ALA GLN ALA SER LYS ASP SEQRES 5 A 402 ARG ASN VAL VAL PHE SER PRO TYR GLY VAL ALA SER VAL SEQRES 6 A 402 LEU ALA MET LEU GLN LEU THR THR GLY GLY GLU THR GLN SEQRES 7 A 402 GLN GLN ILE GLN ALA ALA MET GLY PHE LYS ILE ASP ASP SEQRES 8 A 402 LYS GLY MET ALA PRO ALA LEU ARG HIS LEU TYR LYS GLU SEQRES 9 A 402 LEU MET GLY PRO TRP ASN LYS ASP GLU ILE SER THR THR SEQRES 10 A 402 ASP ALA ILE PHE VAL GLN ARG ASP LEU LYS LEU VAL GLN SEQRES 11 A 402 GLY PHE MET PRO HIS PHE PHE ARG LEU PHE ARG SER THR SEQRES 12 A 402 VAL LYS GLN VAL ASP PHE SER GLU VAL GLU ARG ALA ARG SEQRES 13 A 402 PHE ILE ILE ASN ASP TRP VAL LYS THR HIS THR LYS GLY SEQRES 14 A 402 MET ILE SER ASN LEU LEU GLY LYS GLY ALA VAL ASP GLN SEQRES 15 A 402 LEU THR ARG LEU VAL LEU VAL ASN ALA LEU TYR PHE ASN SEQRES 16 A 402 GLY GLN TRP LYS THR PRO PHE PRO ASP SER SER THR HIS SEQRES 17 A 402 ARG ARG LEU PHE HIS LYS SER ASP GLY SER THR VAL SER SEQRES 18 A 402 VAL PRO MET MET ALA GLN THR ASN LYS PHE ASN TYR THR SEQRES 19 A 402 GLU PHE THR THR PRO ASP GLY HIS TYR TYR ASP ILE LEU SEQRES 20 A 402 GLU LEU PRO TYR HIS GLY ASP THR LEU SER MET PHE ILE SEQRES 21 A 402 ALA ALA PRO TYR GLU LYS GLU VAL PRO LEU SER ALA LEU SEQRES 22 A 402 THR ASN ILE LEU SER ALA GLN LEU ILE SER HIS TRP LYS SEQRES 23 A 402 GLY ASN MET THR ARG LEU PRO ARG LEU LEU VAL LEU PRO SEQRES 24 A 402 LYS PHE SER LEU GLU THR GLU VAL ASP LEU ARG LYS PRO SEQRES 25 A 402 LEU GLU ASN LEU GLY MET THR ASP MET PHE ARG GLN PHE SEQRES 26 A 402 GLN ALA ASP PHE THR SER LEU SER ASP GLN GLU PRO LEU SEQRES 27 A 402 HIS VAL ALA GLN ALA LEU GLN LYS VAL LYS ILE GLU VAL SEQRES 28 A 402 ASN GLU SER GLY THR VAL ALA SER SER SER THR ALA VAL SEQRES 29 A 402 ILE VAL SER ALA ARG MET ALA PRO GLU GLU ILE ILE MET SEQRES 30 A 402 ASP ARG PRO PHE LEU PHE VAL VAL ARG HIS ASN PRO THR SEQRES 31 A 402 GLY THR VAL LEU PHE MET GLY GLN VAL MET GLU PRO HELIX 1 1 HIS A 26 ALA A 49 1 24 HELIX 2 2 SER A 58 LEU A 69 1 12 HELIX 3 3 GLY A 74 GLY A 86 1 13 HELIX 4 4 GLY A 93 MET A 106 1 14 HELIX 5 5 GLY A 107 LYS A 111 5 5 HELIX 6 6 GLY A 131 ARG A 141 1 11 HELIX 7 7 GLU A 151 THR A 167 1 17 HELIX 8 8 GLY A 176 VAL A 180 5 5 HELIX 9 9 LEU A 270 ASN A 275 1 6 HELIX 10 10 SER A 278 GLY A 287 1 10 HELIX 11 11 LEU A 309 GLY A 317 1 9 HELIX 12 12 THR A 319 ARG A 323 5 5 SHEET 1 A 3 THR A 290 PRO A 299 0 SHEET 2 A 3 SER A 221 THR A 238 -1 O MET A 225 N LEU A 298 SHEET 3 A 3 HIS A 208 LEU A 211 -1 O HIS A 208 N MET A 224 SHEET 1 A1 7 THR A 290 PRO A 299 0 SHEET 2 A1 7 SER A 221 THR A 238 -1 O MET A 225 N LEU A 298 SHEET 3 A1 7 HIS A 242 PRO A 250 -1 O HIS A 242 N THR A 238 SHEET 4 A1 7 LEU A 256 PRO A 263 -1 O MET A 258 N LEU A 249 SHEET 5 A1 7 PRO A 380 HIS A 387 -1 N LEU A 382 O ALA A 261 SHEET 6 A1 7 THR A 392 MET A 400 -1 O THR A 392 N HIS A 387 SHEET 7 A1 7 VAL A 56 PHE A 57 -1 N PHE A 57 O MET A 396 SHEET 1 B 6 LYS A 145 VAL A 147 0 SHEET 2 B 6 GLU A 113 GLN A 123 1 O ILE A 120 N LYS A 145 SHEET 3 B 6 LEU A 186 GLN A 197 -1 O VAL A 187 N PHE A 121 SHEET 4 B 6 GLY A 355 VAL A 366 -1 N THR A 356 O GLY A 196 SHEET 5 B 6 VAL A 340 VAL A 351 -1 N ALA A 341 O ILE A 365 SHEET 6 B 6 PHE A 301 ASP A 308 -1 O PHE A 301 N VAL A 351 CRYST1 157.590 47.840 62.880 90.00 107.78 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006346 0.000000 0.002035 0.00000 SCALE2 0.000000 0.020903 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016701 0.00000